Award
NIH Reporter #1R01HD122219-01
The Benefits, Risks, and Long-term Impact of GLP-1 Receptor Agonists in Children
Recipient
Indiana University Indianapolis
Award Amount
$1,589,979.00
Ceiling
$1,589,979.00
Awarded
September 17, 2026
Identifier
1R01HD122219-01
The project will use electronic health records, insurance claims, and other real-world data to study the effects of GLP-1 receptor agonists in children aged 10–18 with obesity or type 2 diabetes. It will develop computable phenotypes, evaluate treatment outcomes and safety, and build a microsimulation model of long-term health outcomes and costs.
Description
NIH-funded project to develop a framework for evaluating the benefits and risks of GLP-1 receptor agonist use in children, using real-world data to assess clinical, mental health, developmental, and long-term outcomes.